Long‑term follow‑up and clinical course of a rare case of von Hippel‑Lindau disease: A case report and review of the literature

Zou,Yu; Xu,Jingjing; Zhang,Minming

doi:10.3892/ol.2016.4387

Long‑term follow‑up and clinical course of a rare case of von Hippel‑Lindau disease: A case report and review of the literature

Authors:
- Yu Zou
- Jingjing Xu
- Minming Zhang
View Affiliations

Affiliations: Department of Radiology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310006, P.R. China, Department of Radiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, P.R. China
Published online on: March 29, 2016 https://doi.org/10.3892/ol.2016.4387
Pages: 3273-3278
Copyright: © Zou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

von Hippel‑Lindau (VHL) disease is an autosomal dominantly inherited neoplastic syndrome that increases susceptibility to a variety of benign and malignant neoplasms. It has been well documented that, despite complete excision of initial neoplasms, VHL patients may develop further lesions, in some cases many years after the initial diagnosis. Therefore, the varied and complex clinical manifestations and radiological findings of VHL are of interest. The current study is the first to describe a case of VHL disease with lateral ventricular hemangioblastomas and subsequent pancreatic neuroendocrine tumor, bilateral renal cysts and renal cell carcinoma. The complete clinical course, radiological findings, including ultrasound, computed tomography and magnetic resonance imaging (MRI), and associated pathological findings are presented. Radiology is critical in the accurate diagnosis, treatment and follow‑up of VHL. Continuous close and long‑term follow‑up with radiological examination, particularly MRI, must be conducted in patients with VHL disease. To the best of our knowledge, the current case is a rare phenomenon that has not yet been described in the English literature.

View Figures

View References

1	Maher ER and Kaelin WG Jr: Von Hippel-Lindau disease. Medicine (Baltimore). 76:381–391. 1997. View Article : Google Scholar : PubMed/NCBI
2	Kaelin WG: Von Hippel-Lindau disease. Annu Rev Pathol. 2:145–173. 2007. View Article : Google Scholar : PubMed/NCBI
3	Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, et al: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 260:1317–1320. 1993. View Article : Google Scholar : PubMed/NCBI
4	Kaelin WG Jr: Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer. 2:673–682. 2002. View Article : Google Scholar : PubMed/NCBI
5	Gossage L, Eisen T and Maher ER: VHL, the story of a tumour suppressor gene. Nat Rev Cancer. 15:55–64. 2014. View Article : Google Scholar
6	Sundaram C, Rammurti S, Reddy JJ, Prasad SS and Purohit AK: Hemangioblastoma: A study of radiopathologic correlation. Neurol India. 51:373–375. 2003.PubMed/NCBI
7	Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM and Oldfield EH: Von Hippel-Lindau disease. Lancet. 361:2059–2067. 2003. View Article : Google Scholar : PubMed/NCBI
8	Batcher E, Madaj P and Gianoukakis AG: Pancreatic neuroendocrine tumors. Endocr Res. 36:35–43. 2011. View Article : Google Scholar : PubMed/NCBI
9	Lee C, Park JW, Suh JH, Nam KH, et al: Histologic variations and immunohistochemical features of metastatic clear cell renal cell carcinoma. Korean J Pathol. 47:426–432. 2013. View Article : Google Scholar : PubMed/NCBI
10	Takeuchi S and Takasato Y: Supratentorial intraventricular hemangioblastomas. Acta Neurol Belg. 111:353–356. 2011.PubMed/NCBI
11	Johnston LB, Chew SL, Lowe D, Reznek R, Monson JP and Savage MO: Investigating familial endocrine neoplasia syndromes in children. Horm Res. 55(Suppl 1): S31–S35. 2001. View Article : Google Scholar
12	Gaal J and de Krijger RR: Neuroendocrine tumors and tumor syndromes in childhood. Pediatr Dev Pathol. 13:427–441. 2010. View Article : Google Scholar : PubMed/NCBI
13	Wanebo JE, Lonser RR, Glenn GM and Oldfield EH: The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg. 98:82–94. 2003. View Article : Google Scholar : PubMed/NCBI
14	Tamura K, Nishimori I, Ito T, et al: Diagnosis and management of pancreatic neuroendocrine tumor in von Hippel-Lindau disease. World J Gastroenterol. 16:4515–4518. 2010. View Article : Google Scholar : PubMed/NCBI
15	Hammel PR, Vilgrain V, Terris B, Penfornis A, Sauvanet A, Correas JM, Chauveau D, Balian A, Beigelman C, O'Toole D, et al: Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau. Gastroenterology. 119:1087–1095. 2000. View Article : Google Scholar : PubMed/NCBI
16	Chetty R, Kennedy M, Ezzat S and Asa SL: Pancreatic endocrine pathology in von Hippel-Lindau disease: An expanding spectrum of lesions. Endocr Pathol. 15:141–148. 2004. View Article : Google Scholar : PubMed/NCBI
17	Blansfield JA, Choyke L, Morita SY, Choyke PL, Pingpank JF, Alexander HR, Seidel G, Shutack Y, Yuldasheva N, Eugeni M, et al: Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL manifested by pancreatic neuroendocrine neoplasms (PNETs). Surgery. 142:814–818; discussion 818.e1–e2. 2007. View Article : Google Scholar : PubMed/NCBI
18	Mukhopadhyay B, Sahdev A, Monson JP, Besser GM, Reznek RH and Chew SL: Pancreatic lesions in von Hippel-Lindau disease. Clin Endocrinol (Oxf). 57:603–608. 2002. View Article : Google Scholar : PubMed/NCBI
19	Chetty R, Kennedy M, Ezzat S and Asa SL: Pancreatic endocrine pathology in von Hippel-Lindau disease: An expanding spectrum of lesions. Endocr Pathol. 15:141–148. 2004. View Article : Google Scholar : PubMed/NCBI
20	Nickerson ML, Jaeger E, Shi Y, Durocher JA, Mahurkar S, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, et al: Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin Cancer Res. 14:4726–4734. 2008. View Article : Google Scholar : PubMed/NCBI
21	Patard JJ, Shvarts O, Lam JS, Pantuck AJ, Kim HL, Ficarra V, Cindolo L, Han KR, De La Taille A, Tostain J, et al: Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol. 171:2181–2185; quiz 2435. 2004. View Article : Google Scholar : PubMed/NCBI
22	Bratslavsky G, Liu JJ, Johnson AD, Sudarshan S, Choyke PL, Linehan WM and Pinto PA: Salvage partial nephrectomy for hereditary renal cancer: Feasibility and outcomes. J Urol. 179:67–70. 2008. View Article : Google Scholar : PubMed/NCBI